Inventor
SAKO DIANNE S
US26 patents
⚠️ This page may combine multiple inventors who share the name “SAKO DIANNE S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACCELERON PHARMA INC
15 patentsUS9809637B2Nov 7, 2017
Transforming growth factor beta receptor II fusion polypeptides
ACCELERON PHARMA INC19 citations92
US9975934B2May 22, 2018
Follistatin-related fusion proteins
ACCELERON PHARMA INC3 citations73
US10316076B2Jun 11, 2019
Transforming growth factor-beta receptor type II fusion polypeptides
ACCELERON PHARMA INC3 citations72
US12421295B2Sep 23, 2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof
ACCELERON PHARMA INC0 citations62
US12195519B2Jan 14, 2025
Transforming growth factor-beta (TGF-beta) receptor type II fusion polypeptides
ACCELERON PHARMA INC0 citations62
US12054753B2Aug 6, 2024
Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers
ACCELERON PHARMA INC0 citations62
US12024563B2Jul 2, 2024
ALK7 antagonists and uses thereof
ACCELERON PHARMA INC0 citations62
US11440949B2Sep 13, 2022
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof
ACCELERON PHARMA INC1 citations62
US11021527B2Jun 1, 2021
Transforming growth factor beta receptor type II fusion polypeptides
ACCELERON PHARMA INC0 citations62
US11008377B2May 18, 2021
Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides
ACCELERON PHARMA INC0 citations62
US11001614B2May 11, 2021
Method for treating a muscle-related disorder with follistatin-related fusion proteins
ACCELERON PHARMA INC1 citations62
US10981973B2Apr 20, 2021
Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide
ACCELERON PHARMA INC0 citations62
US10934532B2Mar 2, 2021
ALK4.ActRIIB heteromultimers
ACCELERON PHARMA INC0 citations62
US12168683B2Dec 17, 2024
Binders of TGFβ-superfamily ligands and uses thereof
ACCELERON PHARMA INC0 citations47
US12103959B2Oct 1, 2024
Multispecific binders of TGFBeta-superfamily ligands and uses thereof
ACCELERON PHARMA INC0 citations47
GENETICS INST
4 patentsUS5827817AOct 27, 1998
P-selectin ligand protein
GENETICS INST146 citations98
US5840679ANov 24, 1998
Method of inhibiting P-selectin ligand activity
GENETICS INST98 citations97
US6277975B1Aug 21, 2001
Fusions of P-selectin ligand protein and polynucleotides encoding same
GENETICS INST34 citations95
US5843707ADec 1, 1998
Nucleic acid encoding a novel P-selectin ligand protein
GENETICS INST71 citations95
GENETICS INST LLC
3 patentsUS7563760B2Jul 21, 2009
P-selectin ligand protein
GENETICS INST LLC23 citations92
US7049128B2May 23, 2006
Platelet glycoprotein Ibα fusion polypeptides and methods of use thereof
GENETICS INST LLC1 citations59
US7927835B2Apr 19, 2011
Nucleic acids encoding P-selectin ligand fusion proteins
GENETICS INST LLC0 citations51
BRIGHAM & WOMENS HOSPITAL INC
2 patentsUS10682392B2Jun 16, 2020
Methods for treating pulmonary hypertension with a TGF-beta type II receptor-FC fusion protein
BRIGHAM & WOMENS HOSPITAL INC4 citations73
US11951156B2Apr 9, 2024
Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor
BRIGHAM & WOMENS HOSPITAL INC1 citations62